Retention of Sample-USFDA [GxP / QC / QA]

posted by kapil pandya – 2010-11-12 13:38 (5704 d 22:31 ago) – Posting: # 6141
Views: 6,857

The sponsor may not reveal the quantity of in-vitro tests for the sake of confidentiality, but they may provide a statement that the remaining quantity of IP is sufficient for retention as per USFDA guideline.

Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Ohlbe]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
334 visitors (0 registered, 334 guests [including 14 identified bots]).
Forum time: 13:09 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5